Feasibility of a Randomized Controlled Mixed Methods Trial to Address Health Literacy, Beliefs, Medication Adherence, and Self-Efficacy (ADHERE) in a Clinical Pharmacist-Led Clinic
Olayinka O Shiyanbola,Martha A Maurer,Natasha Virrueta,Denise L Walbrandt Pigarelli,Yen-Ming Huang,Elizabeth J Unni,Paul D Smith
DOI: https://doi.org/10.2147/PPA.S349258
2022-03-10
Patient Preference and Adherence
Abstract:Olayinka O Shiyanbola, 1 Martha A Maurer, 2 Natasha Virrueta, 1 Denise L Walbrandt Pigarelli, 3 Yen-Ming Huang, 4 Elizabeth J Unni, 5 Paul D Smith 6 1 Division of Social and Administrative Sciences, School of Pharmacy, University of Wisconsin- Madison, Madison, WI, USA; 2 Sonderegger Research Center, School of Pharmacy, University of Wisconsin-Madison, Madison, WI, USA; 3 Division of Pharmacy Practice, School of Pharmacy, University of Wisconsin-Madison, Madison, WI, USA; 4 Graduate Institute of Clinical Pharmacy, College of Medicine, National Taiwan University, Taipei City, Taiwan; 5 Department of Social, Behavioral, and Administrative Sciences, Touro College of Pharmacy, New York, NY, USA; 6 Department of Family Medicine and Community Health, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA Correspondence: Olayinka O Shiyanbola, Division of Social and Administrative Sciences, School of Pharmacy, University of Wisconsin-Madison, 777 Highland Avenue, Madison, WI, 53705, USA, Tel +1 608 890 2091, Email Purpose: To assess the feasibility and acceptability of a health literacy-psychosocial support intervention – ADHERE and explore changes in glycemic values and medication adherence. Patients and Methods: Thirty-one participants with hemoglobin A1c (HbA1c) ≥ 8% were randomly allocated to control (usual care) or intervention groups (receiving usual care plus a 6-session pharmacist-led intervention focusing on the modifiable psychosocial factors that may influence medication adherence). Feasibility metrics evaluated recruitment, retention, and intervention adherence. Questionnaires were administered to collect psychosocial factors and self-reported medication adherence at baseline, the end of the intervention, 3 months, and 6 months post intervention. HbA1c values were extracted from electronic medical records. Repeated measures analysis of variance was used to compare differences in mean outcomes between the control and intervention groups. To assess intervention acceptability, eleven individuals participated in semi-structured interviews about their intervention experiences. Qualitative content analysis was used for analyzing the interviews. Results: Thirty participants completed the study. Overall, the findings support the feasibility of the intervention. There were significant differences in HbA1c values. Participants in the intervention group had lower A1C (8.3 ± 1.4) than in the control group (9.2 ± 1.3) at the time of 6-month follow-up (p = 0.003). In addition, the participants in the intervention group showed improved HbA1c at 6-month follow-up (8.3 ± 1.4), compared to baseline (9.4 ± 1.5, p = 0.011) and after 6-session intervention (8.9 ± 1.6, p = 0.046). However, there were no significant differences in medication adherence between groups over time. Qualitative themes suggest participants liked the intervention and perceived the additional support from the pharmacist as beneficial. Conclusion: A pharmacist-led intervention to provide additional health literacy-psychosocial support may contribute to long-term improvements in HbA1c. Equipping pharmacists with patient-specific diabetes medication adherence information and building in additional follow-up support for patients may improve patient health outcomes. Keywords: type 2 diabetes, medication adherence, health literacy, hemoglobin A1c, self-efficacy Diabetes remains one of the most prevalent health conditions in the US. In 2018, 34.2 million Americans had diabetes, and in 2017, diabetes was ranked the seventh leading cause of death with the total costs of diabetes as $327 billion. 1 Diabetes medication adherence rates are reported as low as 36%. 2 According to the World Health Organization, improving medication adherence may have a larger influence on patient outcomes and socioeconomic burden than addressing treatment improvements. 3 Improving medication adherence (henceforth called "adherence") is also important for self-management of diabetes. 4,5 A systematic review summarizing pharmacist-led activities to manage type 2 diabetes (T2D) reported that involving a pharmacist resulted in improved economic, health, and humanistic outcomes. 6 Pharmacists have the capability to positively influence medication adherence in patients with diabetes in a variety of ways, including providing patient education, enhancing positive reinforcement for support in medication adherence, helping patients formulate a medication treatment plan; initiating or modifying medication therapy; monitoring patient response to therapy; and identifying, resolving, and preventing a -Abstract Truncated-
medicine, general & internal